These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7940853)

  • 1. Behavior of International Society for Heart and Lung Transplantation grade 2 cardiac rejection.
    Milano A; Livi U; Caforio AL; Bianco R; Casula R; Gambino A; Feltrin G; Legittimo A; Angelini A; Thiene G
    Transplant Proc; 1994 Oct; 26(5):2724. PubMed ID: 7940853
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
    Heroux AL; LeBlanc MH; Beaudoin D; Simard S; Coulombe DA; Gleeton O; Lemieux MD; Doyle DP
    Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of cyclosporine dose on long-term outcome after heart transplantation.
    Valantine H; Hunt S; Gamberg P; Miller J; Luikart H
    Transplant Proc; 1994 Oct; 26(5):2710-2. PubMed ID: 7940848
    [No Abstract]   [Full Text] [Related]  

  • 5. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of HLA-DR matching on rejection after cardiac transplantation.
    Cochrane A; Benson E; Williams T; Bergin P; Esmore D
    Transplant Proc; 1992 Feb; 24(1):169-70. PubMed ID: 1539227
    [No Abstract]   [Full Text] [Related]  

  • 8. FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
    Knoop C; Antoine M; Vachiéry JL; Yernault JC; Estenne M
    Transplant Proc; 1994 Dec; 26(6):3240-1. PubMed ID: 7527957
    [No Abstract]   [Full Text] [Related]  

  • 9. Design and evaluation of a computer tool to aid early management of cyclosporine therapy after heart and heart-lung transplantation.
    Best NG; Tan KK; Trull AK; Spiegelhalter DJ; Hue KL; Caine N; Wallwork J
    Transplant Proc; 1994 Oct; 26(5):2716-7. PubMed ID: 7940850
    [No Abstract]   [Full Text] [Related]  

  • 10. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical problems in pediatric heart and heart-lung transplantation. Transplant Team.
    Cicini MP; Marcelletti C
    Rays; 1994; 19(3):366-77. PubMed ID: 7800844
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary rejection diagnosis after lung and heart-lung transplantation.
    Reichenspurner H; Dienemann H; Rihl M; Wagner F; Meiser BM; Kur F; Hammer C; Forst H; Kreuzer E; Reichart B
    Transplant Proc; 1993 Dec; 25(6):3299-300. PubMed ID: 8266550
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation.
    Jennison SH; Wesp AG; McBride LR; Miller LW
    Transplant Proc; 1994 Oct; 26(5):2732-5. PubMed ID: 7940857
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K
    J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
    Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C
    Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal clinical regimens for living related liver transplantation.
    Malagó M; Rogiers X; Wadström J; Burdelski M; Broelsch CE
    Transplant Proc; 1994 Oct; 26(5):2665-8. PubMed ID: 7940834
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal effects of cyclosporine administration at 0 to 60 months after heart transplantation.
    Costanzo MR; Beto JA; Potempa LD; Bansal VK; Heroux AL; Kao WG; Pifarre R; Johnson MR
    Transplant Proc; 1994 Oct; 26(5):2704-9. PubMed ID: 7940847
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up after heart transplantation in Chagas' disease.
    Bocchi EA; Bellotti G; Uip D; Kalil J; de Lourdes Higuchi M; Fiorelli A; Stolf N; Jatene A; Pilleggi F
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1329-30. PubMed ID: 8442131
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
    Transplant Proc; 1994 Oct; 26(5):2749. PubMed ID: 7940864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.